Latest news from across our Group

24-Jul-25

Convatec secures US and European regulatory clearance for Aquacel™ ConvaFiber™ wound care innovation

15-Jul-25

Convatec responds to CMS draft payment proposal for skin substitutes in the United States

01-Jul-25

Comment on CMS proposed rule change issued 30 June 2025

26-Jun-25

Convatec welcomes regulatory approval of subcutaneous apomorphine infusion for advanced Parkinson’s disease in the US

22-May-25

AGM trading update for the four months ended 30 April 2025

20-May-25

Advancing subcutaneous infusion therapy for patients through innovation and partnerships

25-Apr-25

Convatec receives regulatory approval for ConvaNiox™

11-Apr-25

Convatec welcomes postponement of Local Coverage Determinations (LCDs) on skin substitutes until January 2026

31-Mar-25

Convatec announces exclusive collaboration with largest Wound, Ostomy and Continence professional nursing organisation

18-Mar-25

Convatec showcases its strongest wound care innovation pipeline ever at EWMA

26-Feb-25

Annual results for the year ended 31 December 2024

26-Jan-25

Convatec welcomes the postponement of Local Coverage Determinations (LCDs) on skin substitutes in the United States